China Pharma Holdings (CPHI) EBT Margin (2010 - 2026)
China Pharma Holdings' (CPHI) quarterly EBT Margin came in at 116.23% in Q1 2026, down 4709.0% YoY from 2.52% in Q1 2025, and down 16.6% on a QoQ basis from 99.68% in Q4 2025.
China Pharma Holdings (CPHI) EBT Margin (2010 - 2026) Analysis & Trends
China Pharma Holdings (CPHI) has 17 years of EBT Margin data on file, last reported at 116.23% in Q1 2026.
- Quarterly EBT Margin fell 4709.0% year-over-year to 116.23% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 88.82% (up 1748.0% YoY) and the FY2025 annual result came in at 76.91%, up 2767.0% from the prior year.
- EBT Margin declined to 116.23% in Q1 2026, from 99.68% in the prior quarter.
- In the past five years, EBT Margin ranged from a high of 24.28% in Q1 2023 to a low of 155.48% in Q2 2024.
- A 5-year average of 72.89% and a median of 64.18% in 2022 frame the typical range for EBT Margin.
- Annual changes were most pronounced in 2024 — EBT Margin sank 10147 bps — and 2025, when it soared 10397 bps.
- Tracing CPHI's EBT Margin over 5 years: stood at 43.28% in 2022, then tumbled by 32 bps to 57.32% in 2023, then sank by 88 bps to 107.98% in 2024, then gained by 8 bps to 99.68% in 2025, then decreased by 17 bps to 116.23% in 2026.
- The last three EBT Margin figures came in at 116.23% (Q1 2026), 99.68% (Q4 2025), and 86.15% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | -10.99% |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 35.09% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 13.34% |
| 5 | United Therapeutics | 22.19 Bn | 19.53 Bn | 683.80 Mn | 47.58% |
| 6 | Viatris | 18.68 Bn | 17.79 Bn | 1.46 Bn | -1.70% |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 16.91% |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 4.09% |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | China Pharma Holdings | 42.70 Mn | 42.39 Mn | 83,566.00 | -153.76% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -116.23% |
| Dec 31, 2025 | -99.68% |
| Sep 30, 2025 | -86.15% |
| Jun 30, 2025 | -51.51% |
| Mar 31, 2025 | -69.13% |
| Dec 31, 2024 | -107.98% |
| Sep 30, 2024 | -101.61% |
| Jun 30, 2024 | -155.48% |
| Mar 31, 2024 | -69.78% |
| Dec 31, 2023 | -57.32% |
| Sep 30, 2023 | -43.12% |
| Jun 30, 2023 | -54.02% |
| Mar 31, 2023 | -24.28% |
| Dec 31, 2022 | -43.28% |
| Sep 30, 2022 | -40.22% |
| Jun 30, 2022 | -55.07% |
| Mar 31, 2022 | -64.18% |
| Dec 31, 2021 | -33.94% |
| Sep 30, 2021 | -41.78% |
| Jun 30, 2021 | -34.14% |